Related Experiment Video
Updated: May 6, 2026
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Pediatric Bullous Pemphigoid Treated With Dupilumab: A Case Report With Good Response
Aldana Belén Almassio1, Laura Luna2, Margarita Larralde1,3
1Pediatric Dermatology Section, Hospital Ramos Mejía, Buenos Aires, Argentina.
Abstract:
Bullous pemphigoid (BP) is an autoimmune blistering disorder predominantly affecting the elderly, with rare occurrences in children. We report a case of a 3-year-old girl with BP who initially failed conventional treatments but achieved complete remission following dupilumab therapy. This case suggests that dupilumab could be an effective and safe alternative for pediatric BP resistant to standard therapies, though further studies are needed to confirm its efficacy.
